Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB

Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB

by | Jul 13, 2023 3:14 pm | Medical Office Buildings, Other Services

JLL Capital Markets announced on July 12 that it advised on the acquisition of a 53,120-square-foot medical office building (MOB) in Hamden, Connecticut. According to data captured in the LevinPro HC database, this represents the 120th MOB transaction of 2023 JLL represented Sendero Capital and Angelo Gordon, who have formed a programmatic joint venture (also arranged by JLL) for up to $300 million in investments in outpatient healthcare real estate over the next two years, in the acquisition. The purchase of the Hamden MOB is the first acquisition as part of the joint venture, which will focus on value-add and core plus outpatient medical office and surgery center assets throughout the... Read More »
CROs Are Still Trending as Q4 Rolls On

CROs Are Still Trending as Q4 Rolls On

by | Nov 10, 2019 10:26 am | CRO, Other Services, Private Equity

In the first week of November, BioAgilytix Labs, LLC, a portfolio company of Riverside Partners, purchased Cambridge Biomedical. Both Cambridge and BioAgilytix are contract research organizations (CROs) that develop novel therapeutic biologics and biosimilars, specializing in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-accredited, and GLP-compliant facility with its GxP laboratories in Durham, North Carolina and Hamburg, Germany. It also gives BioAgilytix a total of 400 employees. The merger follows a busy October for CROs, in which five deals were reported, accounting for... Read More »

eHealth Deals Remain Active in August

by | Sep 3, 2019 11:21 am | eHealth, Private Equity

August proved to be another busy month for eHealth transactions. According to our Deal Search Online database, there were 18 acquisitions in the eHealth sector in July 2019, and 17 in August. The most popular targets this month were cloud-based and data-analytics providers. There were eight digital health transactions with that focus, including Water Street Healthcare Partners and JLL Partners’ acquisition of THREAD, a virtual research platform used by biopharma, contract research organizations, not-for-profit researchers and life science organizations to capture global clinical study data for clinical studies. Water Street and JLL will invest to further develop and expand... Read More »
MedPlast Adds Integer’s Surgical and Orthopedics Lines

MedPlast Adds Integer’s Surgical and Orthopedics Lines

by | May 31, 2018 11:16 am | Medical Devices

MedPlast Inc., a portfolio company of JLL Partners and Water Street Healthcare Partners, announced the largest deal in the Medical Device sector in May 2018. The company, which provides integrated custom plastic processing solutions for finished medical devices, acquired the advanced surgical and orthopedics lines (ASO) from Integer (NYSE: ITGR) for $600 million. The transaction includes 10 manufacturing facilities. The ASO business comprises products and services for the laparoscopy, general surgery, biopsy and drug delivery, arthroscopic devices and components and orthopedic markets. Integer, formerly known as Greatbatch, rebranded in 2016 under the Integer name. With this acquisition,... Read More »

Patheon Bought, Again

by | May 15, 2017 8:28 pm | CRO, Laboratories, MRI & Dialysis, Other Services, Private Equity

There has been a lot of interest in contract research organizations (CROs), contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs), especially in the M&A market. Half-way through May 2017, 19 of these deals have been  announced. With 14 deals and $14 billion spent this year, CROs have taken the spotlight. But CDMO deals are picking up pace, accounting for 21% of the 19 deals and $7.3 billion spent this year. Most of that total derives from one deal. On May 15, 2017, Thermo Fisher Scientific, Inc. (NYSE: TMO) acquired Patheon N.V. (NYSE: PTHN), a CDMO focused on active pharmaceutical ingredients (APIs) and finished drug product... Read More »